GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » APT Medical Inc (SHSE:688617) » Definitions » Capex-to-Revenue

APT Medical (SHSE:688617) Capex-to-Revenue : 0.27 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is APT Medical Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

APT Medical's Capital Expenditure for the three months ended in Mar. 2024 was ¥-123.40 Mil. Its Revenue for the three months ended in Mar. 2024 was ¥455.33 Mil.

Hence, APT Medical's Capex-to-Revenue for the three months ended in Mar. 2024 was 0.27.


APT Medical Capex-to-Revenue Historical Data

The historical data trend for APT Medical's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

APT Medical Capex-to-Revenue Chart

APT Medical Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial 0.17 0.09 0.20 0.12 0.12

APT Medical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.08 0.13 0.13 0.15 0.27

Competitive Comparison of APT Medical's Capex-to-Revenue

For the Medical Devices subindustry, APT Medical's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


APT Medical's Capex-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, APT Medical's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where APT Medical's Capex-to-Revenue falls into.



APT Medical Capex-to-Revenue Calculation

APT Medical's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-202.029) / 1650.212
=0.12

APT Medical's Capex-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-123.402) / 455.327
=0.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


APT Medical  (SHSE:688617) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


APT Medical Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of APT Medical's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


APT Medical (SHSE:688617) Business Description

Traded in Other Exchanges
N/A
Address
No. 11, Songpingshan Langshan Road, Xili Street, Room 601, Building B, Tongfang Information Port, Songpingshan Community, Nanshan District, Guangdong Province, Shenzhen, CHN, 518000
APT Medical Inc is engaged in the research and development, production and sales of electrophysiological and vascular interventional medical devices for cardiovascular and cerebrovascular diseases. Its products are sold in Europe, Eastern Europe, Southeast Asia and other countries and other regions.
Executives
Dai Zhen Hua Directors, senior managers
Cheng Zheng Hui Directors, senior managers
Zhang Yong Core technical personnel
Liu Fang Yuan senior management
Wang Wei senior management
Senior management, core technical personnel
Xu Yi Qing Directors, senior managers
Han Yong Gui Senior management, core technical personnel

APT Medical (SHSE:688617) Headlines

No Headlines